An Open-Label Study of 50 Mg Oral Testosterone Undecanoate (Kyztrex) in Menopausal Women with Low Testosterone and HSDD
Part of paid clinical trials in San Diego, California.
- Sponsor
- San Diego Sexual Medicine
- Study ID
- NCT06082817
- Phase
- PHASE2
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Hypoactive Sexual Desire Disorder
Eligibility Criteria
- Sex
- FEMALE
- Age
- 21 Years - 75 Years
- Healthy Volunteers
- Accepted
Interventions
- Oral Testosterone Undecanoate — DRUG50mg oral testosterone undecanoate daily
Study Details
This is an unblinded study to be conducted at a single research center, San Diego Sexual Medicine. Eligible subjects will receive 50 mg capsules of Kyzatrax® to be taken orally daily over a 3-month period. Multiple blood samples will be taken at baseline and on days 7, 28 and 56 to assess safety and pharmacokinetics of the testosterone. After the informed consent is signed and for up to 14 days after the last dose of study drug, participants will have serial blood samples collected in addition to other routine study procedures (e.g. vital signs measured, adverse events assessed, validated outcome scales completed).
Key Dates
- Start date
- Jan 1, 2025
- Status verified
- Nov 2024
- Primary completion
- Dec 31, 2025
- Completion
- Dec 31, 2025
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: ActiveParticipants will receive 50mg oral testosterone undecanoate daily, have pharmacokinetics assessed and complete validated instruments
Primary Outcome Measure
Testosterone [ Time Frame: days 0, 7, 28, 56 ]
Central Contacts
- Sue W Goldstein, BA619-265-8865
- Claudia Gardner, BA619-265-8865
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| San Diego Sexual Medicine | San Diego | California | 92120 | - |
Find similar trials in San Diego, CA
Related Studies
- BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed Hypoactive Sexual Desire DisorderPHASE1/PHASE2 · Not Yet Recruiting · University of Illinois at Chicago · Chicago, Illinois